Benzinga's Top #PreMarket Gainers

Repros Therapeutics

shares jumped 15.51% to $10.35 in pre-market trading following the announcement that Androxal ZA-304 study has met primary endpoint. Nike

shares surged 6.80% to $85.17 in pre-market trading after the company reported stronger-than-expected fiscal first-quarter results. Analysts at Janney Capital upgraded Nike from Neutral to Buy. Diamond Foods

shares surged 5.79% to $28.16 in pre-market trading after the company reported fiscal fourth-quarter results. Micron Technology

shares climbed 5.17% to $33.34 in pre-market trading after the company posted better-than-expected fiscal fourth-quarter results and issued a strong revenue forecast for the fiscal first quarter.